UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Although the exact cause of multiple sclerosis (MS) is unknown, a number of genetic and environmental factors are thought to influence MS susceptibility. One potential environmental factor is sunlight and the subsequent production of vitamin D. A number of studies have correlated decreased exposure to UV radiation (UVR) and low serum 25-hydroxyvitamin D 3 [25(OH)D 3 ] levels with an increased risk for developing MS. Furthermore, both UVR and the active form of vitamin D, 1α,25-dihydroxyvitamin D 3 , suppress disease in the experimental autoimmune encephalomyelitis (EAE) animal model of MS. These observations led to the hypothesis that UVR likely suppresses disease through the increased production of vitamin D. However, UVR can suppress the immune system independent of vitamin D. Therefore, it is unclear whether UVR, vitamin D, or both are necessary for the putative decrease in MS susceptibility. We have probed the ability of UVR to suppress disease in the EAE model of MS and assessed the effect of UVR on serum 25(OH)D 3 and calcium levels. Our results indicate that continuous treatment with UVR dramatically suppresses clinical signs of EAE. Interestingly, disease suppression occurs with only a modest, transient increase in serum 25(OH)D 3 levels. Further analysis demonstrated that the levels of 25(OH)D 3 obtained upon UVR treatment were insufficient to suppress EAE independent of UVR treatment. These results suggest that UVR is likely suppressing disease independent of vitamin D production, and that vitamin D supplementation alone may not replace the ability of sunlight to reduce MS susceptibility.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Of Mice and Not Men: Differences between Mouse and Human Immunology
Mestas, J., & Hughes, C. C. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2731 · Cited by 3,822 · cited 1×
“Potential caveats to this hypothesis include important differencesbetween the immunesystemsofmiceandhumans (33), as well as betweenMSandEAE(34).”
BackgroundNoseworthy, J. H., Lucchinetti, C., Rodriguez, M., & Weinshenker, B. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431307 · Cited by 2,899
Overview of general physiologic features and functions of vitamin D
DeLuca, H. F. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.6.1689s · Cited by 2,327 · cited 1×
“The 25(OH)D3 metabolite is the primary circulating form of vitamin D3 and is commonly used as a clinical indicator of vitaminD status (16).”
BackgroundSelf-citationSerum 25-Hydroxyvitamin D Levels and Risk of Multiple Sclerosis
Munger, K. L., Levin, L. I., Hollis, B. W., Howard, N. S., & Ascherio, A. (2006) · JAMA · doi:10.1001/jama.296.23.2832 · Cited by 1,897
Compston, A., & Coles, A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08220-x · Cited by 1,743
Vitamin D Status: Measurement, Interpretation, and Clinical Application
Holick, M. F. (2009) · Annals of Epidemiology · doi:10.1016/j.annepidem.2007.12.001 · Cited by 1,286
Unique Biosynthesis by Kidney of a Biologically Active Vitamin D Metabolite
FRASER, D. R., & KODICEK, E. (1970) · Nature · doi:10.1038/228764a0 · Cited by 1,281 · cited 1×
“The second activation step occurs in the kidney and involves the stereospecifichydroxylationof 25(OH)D3at carbon1 toyield1,25(OH)2D3(17,18).”
BackgroundCurrent Understanding of the Molecular Actions of Vitamin D
JONES, G., STRUGNELL, S. A., & DeLUCA, H. F. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.4.1193 · Cited by 1,274 · cited 1×
“UVB wavelengths between 270 and 300 nm stimulate the production of previtamin D3 from the cholesterol derivative 7-dehydrocholesterol (14).”
BackgroundSelf-citationCantorna, M. T., Hayes, C. E., & DeLuca, H. F. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7861 · Cited by 718 · cited 2×
“Additional evidence linking vitamin D and MS is the observation that treatment with the active form of vitamin D, 1,25(OH)2D3 suppresses EAE (23, 24).”
BackgroundSelf-citationEnvironmental factors and multiple sclerosis
Ebers, G. C. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70042-5 · Cited by 629 · cited 2×
“Although the exact cause of MS is unknown, a number of genetic and environmental factors are thought to influence MS development (3).”
BackgroundHolick, M. F., MacLaughlin, J. A., & Doppelt, S. H. (1981) · Science · doi:10.1126/science.6256855 · Cited by 558 · cited 1×
“These factors include the photochemical conversion of previtamin D3 into biologically inert compounds, skin pigmentation, and latitude (27).”
Background25-Hydroxycholecalciferol. A biologically active metabolite of vitamin D3
Blunt, J. W., DeLuca, H. F., & Schnoes, H. K. (1968) · Biochemistry · doi:10.1021/bi00850a001 · Cited by 548 · cited 1×
“The first activation step occurs in the liver, where vitamin D3 is hydroxylated at carbon-25 to generate 25-hydroxyvitamin D3 [25 (OH)D3] (15).”
BackgroundSelf-citationAntigenicity of Murine Skin Tumors Induced by Ultraviolet Light2
Kripke, M. L. (1974) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/53.5.1333 · Cited by 478 · cited 1×
“In addition to directly damaging DNA, UVR can induce carcinogenesis by suppressing the immune system (8, 9).”
BackgroundLemire, J. M., & Archer, D. C. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115072 · Cited by 472 · cited 1×
“Additional evidence linking vitamin D and MS is the observation that treatment with the active form of vitamin D, 1,25(OH)2D3 suppresses EAE (23, 24).”
BackgroundFisher, M. S., & Kripke, M. L. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.4.1688 · Cited by 397
The immunological functions of the vitamin D endocrine system.
Hayes, C. E., Nashold, F. E., Spach, K. M., & Pedersen, L. B. (2003) · PubMed · Cited by 371
Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia
Mei, I. A. F., Ponsonby, A.-L., Dwyer, T., Blizzard, L., Taylor, B. V., Kilpatrick, T., Butzkueven, H., & McMichael, A. J. (2007) · Journal of Neurology · doi:10.1007/s00415-006-0315-8 · Cited by 321 · cited 1×
“Support for this hypothesis is derived from studies indicating that decreased exposure to UVR and decreased 25(OH)D3 levels are associated with a higher risk for developingMS (22, 31).”
Holick, M. F., Schnoes, H. K., & DeLuca, H. F. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.803 · Cited by 277
Self-citationAcheson, E. D., Bachrach, C. A., & Wright, F. M. (1960) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1960.tb08674.x · Cited by 277 · cited 2×
“Findings that the average annual hours of sunlight exposure in an individual’s place of birth is inversely correlated with MS development support this hypothesis (5, 6).”
BackgroundVirtues and pitfalls of EAE for the development of therapies for multiple sclerosis
Steinman, L., & Zamvil, S. S. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.08.014 · Cited by 265 · cited 1×
“Potential caveats to this hypothesis include important differencesbetween the immunesystemsofmiceandhumans (33), as well as betweenMSandEAE(34).”
BackgroundMattner, F., Smiroldo, S., Galbiati, F., Müller, M., Lucia, P. D., Poliani, P. L., Martino, G., Panina‐Bordignon, P., & Adorini, L. (2000) · European Journal of Immunology · doi:10.1002/1521-4141(200002)30:2<498::aid-immu498>3.0.co;2-q · Cited by 247
Monthly Ambient Sunlight, Infections and Relapse Rates in Multiple Sclerosis
Tremlett, H. L., van der Mei, I. A. F., Pittas, F., Blizzard, L., Paley, G., Mesaros, D., Wood-Baker, R. R., Núñez, M., Dwyer, T., Taylor, B. V., et al. (2008) · Neuroepidemiology · doi:10.1159/000166602 · Cited by 184 · cited 1×
“Indeed, a recent studydemonstrated thatMS relapse rates are lower in the summer than in the winter, suggesting that decreasedUVexposuremaybe a contributing factor in relapses (12).”
BackgroundFreedman, D. M., Dosemeci, M., & Alavanja, M. C. R. (2000) · Occupational and Environmental Medicine · doi:10.1136/oem.57.6.418 · Cited by 168 · cited 1×
“Furthermore, individuals with the highest residential andoccupational solar exposure have the lowest rate ofMS incidence (7).”
BackgroundImpaired Immunity in Vitamin A-Deficient Mice
Smith, S. M., Levy, N. S., & Hayes, C. E. (1987) · Journal of Nutrition · doi:10.1093/jn/117.5.857 · Cited by 156 · cited 1×
“experiments, 8-week-old mice were switched to a purified diet containing all of the essential nutrients for normal growth (39).”
MethodShepard, R. M., & DeLuca, H. F. (1980) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(80)90404-x · Cited by 151 · cited 1×
“It is known that at high plasma levels of 25(OH)D3, it acts as an analog of 1,25(OH)2D3 and increases serum calcium levels (29).”
BackgroundSelf-citationMultiple sclerosis: vitamin D and calcium as environmental determinants of prevalence
Goldberg, P. (1974) · International Journal of Environmental Studies · doi:10.1080/00207237408709630 · Cited by 146 · cited 1×
“The potential link between vitamin D insufficiency and MS was first proposed by Goldberg, based on the geographic distribution of MS and the relationship between UVR and vitamin D production (20).”
BackgroundCantorna, M. T., Humpal-Winter, J., & DeLuca, H. F. (1999) · Journal of Nutrition · doi:10.1093/jn/129.11.1966 · Cited by 129 · cited 4×
“However, complete disease suppression is only achieved using supraphysiological doses of 1,25 (OH)2D3, which cause vitamin D toxicity and hypercalcemia (26).”
BackgroundInfluentialSelf-citationThe Geographic Distribution of Multiple Sclerosis: A Review
Ebers, G. C., & Sadovnick, A. D. (1993) · Neuroepidemiology · doi:10.1159/000110293 · Cited by 126
Nashold, F. E., Hoag, K. A., Goverman, J. M., & Hayes, C. E. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00360-5 · Cited by 117
The Effect of Chronic Ultraviolet Radiation on the Human Immune System†
Norval, M., McLoone, P., Lesiak, A., & Narbutt, J. (2008) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2007.00239.x · Cited by 103 · cited 1×
“UVR can suppress the immune system through a number of mechanisms independent of vitamin D, including inhibiting antigen presentation, altering inflammatory cytokine levels, and inducing suppressor T-cell populations (32).”
BackgroundDoes Immunosuppressive Ultraviolet Radiation Explain the Latitude Gradient for Multiple Sclerosis?
McMichael, A. J., & Hall, A. J. (1997) · Epidemiology · doi:10.1097/00001648-199710000-00005 · Cited by 102 · cited 1×
“Although UV-induced immunosuppression clearly has detrimental effects in the context of skin cancer, it may have beneficial effects on organ-specific autoimmune diseases, such asMS (11).”
BackgroundA Biologically Active Metabolite of Vitamin A and Vitamin A Acid
Yagishita, K., Sundaresan, P. R., & Wolf, G. (1964) · Nature · doi:10.1038/203410b0 · Cited by 95
Lucas, R. M., & Ponsonby, A. (2006) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2006.02.019 · Cited by 90 · cited 1×
“However, UVR suppresses the immune system through mechanisms independent of vitamin D (21).”
BackgroundTHE PREVALENCE OF MULTIPLE SCLEROSIS IN AUSTRALIA
Sutherland, J. M., Tyrer, J. H., & Eadie, M. J. (1962) · Brain · doi:10.1093/brain/85.1.149 · Cited by 82
Hauser, S. L., Weiner, H. L., Che, M., SHAPIRO, M. E., Gilles, F. H., & Letvin, N. L. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.132.3.1276 · Cited by 65 · cited 4×
“Discussion In contrast to a previous report (13), 7-day pretreatment with 2.”
BackgroundResultInfluentialNovel insights in the immune function of the vitamin D system: Synergism with interferon-beta
van Etten, E., Gysemans, C. A., Brǎnişteanu, D. D. D., Verstuyf, A., Bouillon, R., Overbergh, L., & Mathieu, C. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.12.094 · Cited by 57
Common Fluorescent Sunlamps are an Inappropriate Substitute for Sunlight ¶
Brown, D. B., Peritz, A. E., Mitchell, D. L., Chiarello, S., Uitto, J., & Gasparro, F. P. (2000) · Photochemistry and Photobiology · doi:10.1562/0031-8655(2000)0720340cfsaai2.0.co2 · Cited by 46
Meehan, T. F., Vanhooke, J. L., Prahl, J. M., & DeLuca, H. F. (2005) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2005.08.011 · Cited by 29 · cited 2×
“Furthermore, results from our laboratory suggest that hypercalcemia is more than simply an unfortunate consequence of 1,25(OH)2D3 treatment, and may play an essential role in the immunosuppressive effects of 1,25(OH)2D3 (28).”
BackgroundSelf-citationPhotoimmunology—illuminating the immune system through photobiology
Leitenberger, J. J., Jacobe, H. T., & Cruz, P. D. (2007) · Seminars in Immunopathology · doi:10.1007/s00281-007-0063-6 · Cited by 27 · cited 1×
“The absorption of UVR by photoreceptors leads to the release of a number of secondary mediators capable of suppressing cell-mediated immunity through multiple mechanisms (10).”
Background
Cited by
Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis
Olsson, T., Barcellos, L. F., & Alfredsson, L. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.187 · Cited by 1,185
Light in diagnosis, therapy and surgery
Yun, S. H., & Kwok, S. J. J. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-016-0008 · Cited by 793
Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression
Ascherio, A., Munger, K. L., White, R., Köchert, K., Simon, K. C., Polman, C. H., Freedman, M. S., Hartung, H.-P., Miller, D. H., Montalbán, X., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.5993 · Cited by 516
Slominski, A. T., Zmijewski, M. A., Skobowiat, C., Zbytek, B., Slominski, R. M., & Steketee, J. D. (2012) · Advances in Anatomy, Embryology and Cell Biology · doi:10.1007/978-3-642-19683-6 · Cited by 496
Vitamin D, disease and therapeutic opportunities
Plum, L. A., & DeLuca, H. F. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3318 · Cited by 477
Self-citation
Metadata
- Authors
- Becklund, B. R., Severson, K. S., Vang, S. V., & DeLuca, H. F.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2010-03-22
- Volume
- 107
- Issue
- 14
- Pages
- 6418-6423
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1986154320
- Cited by
- 199
- References
- 39
- FWCI
- 15.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.